The pharmaceutical company SINCROFARM has entrusted OYTEC with the digitalisation of operations at its two manufacturing plants, covering both pharmaceutical and nutraceutical production. With this project, the company aims to automate and maximise the integrity of its operations while optimising and improving its industrial management model.
Founded in 1990, SINCROFARM is a contract manufacturing and packaging services company for medicines and food supplements for both human and veterinary use. It has state-of-the-art machinery and a total floor area of 7,200 m2, split across two buildings: one for medicines manufacturing and one for nutraceuticals. It has the capacity to handle everything from small and medium-sized batches, with practical, versatile and agile mechanisation, through to large-scale manufacturing, in compliance with GMP certifications for both pharmaceutical products and food supplements/nutraceuticals.
The digitalisation project launched by SINCROFARM covers every area and department of the plant, ranging from replacing the paper batch record with an Electronic Batch Record (eBR), through the digitalisation of laboratory operations (LIMS), to real-time efficiency monitoring (OEE) of its production plants.
Beyond eliminating paper from the plant, this comprehensive digitalisation process launched by SINCROFARM will deliver a significant improvement in the consistency and integrity of operations, a considerable reduction in process deviations and a major reduction in Electronic Batch Record review times. In projects of this kind, significant improvements can be expected in:
⦁ Batch Record review times reduced by more than 75% thanks to Real-Time Review by Exception.
⦁ Reductions of more than 75% in Batch Record and laboratory deviations/investigations.
⦁ Performance improvements of around 10% on filling/packaging lines
⦁ Data entry times reduced by around 75%.
In this way, SINCROFARM aims to have fully digitalised, “Paperless” facilities, ensuring the integrity of its operations and excellence in its management processes in order to provide an outstanding service to its customers.
For more information, contact us at info@oytec.es
Latest News
Fast & Furious eBR Implementation
YES, that's right, a Fast & Furious eBR Implementation is possible. It is no longer a utopia to carry out an Electronic Batch Record implementation in a fast and massive way for any manufacturing plant. Regardless of the manufacturing area: bulk, weighing, or...
EMA and FDA: The 10 Principles of Pharmaceutical AI
The European Union and the United States published the Guiding Principles for Good AI Practices in Drug Development on January 14, 2026, as part of a strategic effort to harmonize regulatory criteria. The EMA-FDA collaborative work initiative has the mission of...
The FDA and Pharmaceutical AI: Key Points from the 2025 Draft on Model Credibility
The FDA positions credibility as an indispensable condition for utilising AI in pharmaceutical regulatory decision-making, within a risk-proportionate framework that demands traceability, transparency and validation throughout the entire model lifecycle. This approach...
